EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A flexible, high-throughput system for studying live mRNA translation with HiBiT technology

Camilla Ascanelli, Elsa Lawrence, Christopher A P Batho, Catherine H Wilson iD

Nucleic Acids Research · 2025

DOI: 10.1093/nar/gkaf496 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Camilla Ascanelli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1PD, United Kingdom. Hauptthemen laut MEDLINE: RNA, Messenger, Protein Biosynthesis, Luciferases, High-Throughput Screening Assays. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Royal Society research, Cambridge BHF Centre of Research Excellence Studentship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HiBiT is an engineered luciferase’s 11-amino-acid component that can be introduced as a tag at either terminus of a protein of interest. When the LgBiT component and a substrate are present, HiBiT and LgBiT dimerize forming a functional luciferase. The HiBiT technology has been extensively used for high-throughput protein turnover studies in cells. Here, we have adapted the use of the HiBiT technology to quantify messenger RNA (mRNA) translation temporally in vitro in the rabbit reticulocyte system and in cellulo in HEK293 cells constitutively expressing LgBiT. The assay system can uniquely detect differences in cap, 5′UTR, modified nucleotide composition, coding sequence optimization and poly(A) length, and their effects on mRNA translation over time. Importantly, using these assays we established the optimal mRNA composition varied depending on the encoded protein of interest, highlighting the importance of screening methods tailored to the protein of interest, and not reliant on reporter proteins. Our findings demonstrated that HiBiT can be easily and readily adapted to monitor real-time mRNA translation in live cells and offers a novel and highly favourable method for the development of mRNA-based therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, MessengerProtein BiosynthesisLuciferasesHigh-Throughput Screening AssaysTranslatingHumansHEK293 CellsAnimalsRabbitsReticulocytes5' Untranslated RegionsRNA Caps

Substanzen

RNA, Messenger5' Untranslated RegionsLuciferasesRNA Caps

Autor:innen und Institutionen

  • Department of Pharmacology, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1PD, United Kingdom.

ORCID-Profile: Catherine H Wilson

Förderung

  • British Heart Foundation
  • Royal Society research
  • Cambridge BHF Centre of Research Excellence Studentship

Zitieren

APA

Ascanelli, C., Lawrence, E., Batho, C. A. P., & Wilson, C. H. (2025). A flexible, high-throughput system for studying live mRNA translation with HiBiT technology. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf496

Vancouver

Ascanelli C, Lawrence E, Batho CAP, Wilson CH. A flexible, high-throughput system for studying live mRNA translation with HiBiT technology. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf496

BibTeX
@article{Ascanelli2025,
  author = {Ascanelli, Camilla and Lawrence, Elsa and Batho, Christopher A P and Wilson, Catherine H},
  title = {A flexible, high-throughput system for studying live mRNA translation with HiBiT technology},
  journal = {Nucleic Acids Research},
  year = {2025},
  doi = {10.1093/nar/gkaf496}
}
Kostenlos starten →